首页> 外文OA文献 >ELLIPSE Study: A Phase 1 study evaluating the tolerance of bevacizumab nasal spray in the treatment of epistaxis in hereditary hemorrhagic telangiectasia.

【2h】

ELLIPSE Study: A Phase 1 study evaluating the tolerance of bevacizumab nasal spray in the treatment of epistaxis in hereditary hemorrhagic telangiectasia.

机译：ELLIpsE研究：一项研究评估贝伐单抗鼻腔喷雾剂治疗遗传性出血性毛细血管扩张症中鼻出血的耐受性。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

International audience

机译：国际观众

著录项

作者
Dupuis-Girod S.; Ambrun A.; Decullier E.; Samson G.; Roux A.; Fargeton A.-E.; Rioufol C.; Schwiertz V.; Disant F.; Chapuis F.; Donazzolo Y.; Paintaud G.; Edery P.; Faure F.;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. Alegori study: efficacy of a bevacizumab nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia (HHT). A randomized trial against placebo with dose selection [J] . Dupuis-Girod S., Fargeton A-E, Paez C., Angiogenesis . 2015,第4期

机译：Alegori研究：贝伐单抗鼻喷雾剂治疗遗传性出血性毛细血管扩张（HHT）鼻epi的疗效。安慰剂选择剂量的随机试验
2. Tempo: efficacy of timolol nasal spray as a treatment for epistaxis in hemorrhagic hereditary telangiectasia. A double-blind, randomized, placebo-controlled trial [J] . Dupuis-Girod S., Hermann R., Pitiot V, Angiogenesis . 2019,第4期

机译：节奏：蒂莫尔鼻腔喷雾作为出血性遗传性毛细管扩诊术术治疗的疗效。双盲，随机，安慰剂对照试验
3. Efficacy of TIMOLOL nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia. A double-blind, randomized, placebo-controlled trial [J] . Sophie Dupuis-Girod, Vincent Pitiot, Cyrille Bergerot, Scientific reports. . 2019,第1期

机译：蒂洛尔鼻腔喷雾作为遗传出血性毛细管扩张术术治疗的疗效。双盲，随机，安慰剂对照试验
4. Experimental and numerical study of nasal spray characteristics and its application in a realistic human nasal cavity [C] . Xuwen TONG, Jingliang DONG, Kiao INTHAVONG, Australasian Fluid Mechanics Society;Australasian fluid mechanics conference . 2016

机译：鼻喷雾特性的实验和数值研究及其在真实人鼻腔中的应用
5. A phase I study of vincristine, escalating doses of irinotecan, temozolomide and bevacizumab (VIT-B) in pediatric and adolescent patients with recurrent or refractory solid tumors of non-hematopoietic origin [D] . Venkatramani, Rajkumar. 2010

机译：长春新碱，伊非替康，替莫唑胺和贝伐单抗（VIT-B）逐步剂量在患有非造血源性复发或难治性实体瘤的儿童和青少年患者中的I期研究
6. Efficacy of TIMOLOL nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia. A double-blind randomized placebo-controlled trial [O] . Sophie Dupuis-Girod, Vincent Pitiot, Cyrille Bergerot, -1

机译：TIMOLOL鼻喷雾剂在遗传性出血性毛细血管扩张中作为鼻epi治疗的功效。一项双盲随机安慰剂对照试验
7. ELLIPSE Study: A Phase 1 study evaluating the tolerance of bevacizumab nasal spray in the treatment of epistaxis in hereditary hemorrhagic telangiectasia. [O] . Dupuis-Girod, S., Ambrun, A., Decullier, E., 2014

机译：ELLIPSE研究：一项评估贝伐单抗鼻喷雾剂在遗传性出血性毛细血管扩张鼻asia治疗中耐受性的第一阶段研究。

ELLIPSE Study: A Phase 1 study evaluating the tolerance of bevacizumab nasal spray in the treatment of epistaxis in hereditary hemorrhagic telangiectasia.

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅